文献速递心律失常

妊娠期室上性心律失常的临床管理

Supraventricular arrhythmia in pregnancy.
PubMed 文献 · Heart · 2022-10-13

妊娠期生理变化易导致新发或复发心律失常,室上性心律失常最常见。本文描述三例复杂病例并综述文献,提出多学科团队制定随访及母胎监测计划,诊断指征与非妊娠女性相同,所有抗心律失常药物均通过胎盘需权衡使用,电复律安全,导管消融可选零透视技术,必要时提前分娩。

要点

  • 妊娠期室上性心律失常常见,多学科团队制定母胎监测计划。
  • 抗心律失常药物均通过胎盘,需权衡胎儿与母体药代动力学变化。
  • 电复律安全,导管消融可选零透视技术,必要时提前分娩。

核心结论

  • 妊娠期室上性心律失常需多学科团队管理,制定妊娠、分娩及产后随访和母胎监测计划。
  • 诊断指征与非妊娠女性相同,抗心律失常药物需考虑胎儿和母体药代动力学变化。
  • 电复律安全,电生理检查及导管消融可在选定患者中采用零透视技术进行,必要时提前分娩是治疗选择。

研究设计与样本

  • 综述性文章,描述三例妊娠期复杂室上性心律失常病例并回顾现有文献。

主要发现

  • 妊娠期生理变化易导致新发或复发心律失常,室上性心律失常最常见且通常良性但可能令人担忧。
  • 所有抗心律失常药物均通过胎盘,治疗时需考虑胎儿及母体药效学和药代动力学改变。
  • 电复律在妊娠期安全,电生理检查及导管消融可在选定患者中进行,优先零透视技术。
  • 有时提前分娩(若胎儿可存活)是最佳治疗选择。

临床怎么用

  • 对有指征的妊娠期心律失常患者,按非妊娠女性标准进行诊断性检查。
  • 必要时使用抗心律失常药物,需同时考虑胎儿和母体药代动力学变化。
  • 电复律安全可用,电生理检查及导管消融可在选定患者中采用零透视技术。
  • 多学科团队(心脏、产科、新生儿)制定妊娠、分娩及产后随访和监测计划。
  • 若病情需要且胎儿可存活,提前分娩可作为治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The physiological changes during pregnancy predispose a woman for the development of new-onset or recurrent arrhythmia. Supraventricular arrhythmia is the most common form of arrhythmia during pregnancy and, although often benign in nature, can be concerning. We describe three complex cases of supraventricular arrhythmia during pregnancy and review the currently available literature on the subject. In pregnancies complicated by arrhythmia, a plan for follow-up and both maternal and fetal monitoring during pregnancy, delivery and post partum should be made in a multidisciplinary team. Diagnostic modalities should be used as in non-pregnant women if there is an indication. All antiarrhythmic drugs cross the placenta, but when necessary, medical treatment should be used with consideration to the fetus and the mother's altered pharmacodynamics and kinetics. Electrical cardioversion is safe during pregnancy, and electrophysiological study and catheter ablation can be performed in selected patients, preferably with zero-fluoroscopy technique. Sometimes, delivering the fetus (if viable) is the best therapeutic option. In this review, we provide a framework for the workup and clinical management of supraventricular arrhythmias in pregnant women, including cardiac, obstetric and neonatal perspectives.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ramlakhan KP, Kauling RM, Schenkelaars N, et al. Supraventricular arrhythmia in pregnancy. Heart. 2022. PMID: 35086889. doi:10.1136/heartjnl-2021-320451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。